601233.SS

The company's capital structure shows a debt-to-equity ratio of 1.53, indicating a significant reliance on debt financing. With total liabilities of 75.198 billion CNY and total equity of 38.325 billion CNY, the company's leverage position is above the typical median for the specialty chemicals industry. The liquidity position is characterized by a current ratio of 0.54, suggesting potential short-term liquidity constraints. Profitability metrics reveal a return on equity of 5.3% and a return on assets of 1.79%. These figures are below the industry benchmarks for specialty chemicals, indicating that the company is underperforming in terms of capital efficiency and asset utilization. The net income of 2.033 billion CNY is supported by an operating income of 2.056 billion CNY, but the company's gross profit margin of 5.5% is constrained by high production costs. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the financial snapshot. This lack of segment and geographic diversification increases exposure to regional economic fluctuations and sector-specific risks. The company's free cash flow is negative at -4.912 billion CNY, driven by capital expenditures of -10.820 billion CNY, which suggests ongoing investment in infrastructure or expansion. Looking ahead, the company's revenue is projected to grow by 8.2% in the current fiscal year and 5.1% in the next fiscal year. This growth trajectory is supported by a stable operating cash flow of 6.423 billion CNY, but the negative free cash flow indicates that capital expenditures are outpacing cash generation. The company's risk assessment highlights medium liquidity risk and low dilution potential, with no significant share issuance expected in the near term. Recent events include a 2026-04 regulatory update affecting chemical exports, which could impact the company's international operations. The company has also filed a 2025-03 annual report disclosing ongoing R&D investments in sustainable chemical processes. Analysts have issued a mean price target of 25.59 CNY, with a median target of 27.50 CNY, reflecting a generally positive outlook despite the company's current financial constraints.